Drug research

Prochymal®

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as Adult Human Mesenchymal Stem Cells; Adult human mesenchymal stem cells; Remestemcel-L

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's DiseaseNCT00482092	Mesoblast, Inc.	Phase 3	Completed	2014-09-15Actual
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)NCT00877903	Mesoblast, Inc.	Phase 2	Completed	2011-05-18Actual
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's DiseaseNCT01233960	Mesoblast, Inc.	Phase 3	Completed	2014-09-15Actual

Mesoblast, Inc.CompletedPrimary completion: 2014-09-15 · Actual

Trial details

Mesoblast, Inc.CompletedPrimary completion: 2011-05-18 · Actual

Trial details

Mesoblast, Inc.CompletedPrimary completion: 2014-09-15 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.